Abcellera Biologics Inc ABCL

$14.82 +0.90 (6.47%)

Valuation

Market cap
4,268,025,000
Revenue TTM
$75,130,000
Net income TTM
$-146,410,000
PE ratio
0.00
Forward PE
—
Profit margin
-194.88%
Debt to equity
0.00

Trading

Volume
9,094,899
Avg volume
6,965,202
Day's range
$14.10 – $15.00
Shares out
306,611,000
Stochastic %K
94%
Beta
1.32
Analysts
Strong Sell
Price target
$16.67

Price

Company profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-medi...

Show more

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc.; and Vertex Pharmaceuticals Incorporated to research, develop, manufacture, and commercialize multispecific T-cell engagers (TCEs) for autoimmune diseases and other conditions. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Industry
Biotechnology
Sector
Healthcare
Phone
604 559 9005
Website
https://www.abcellera.com
Address
150 W 4th Avenue, Vancouver, Canada

Latest news

Stocktwits

Stocktradesmoon Sep 30, 3:12 PM
$ABCL Mid $15’sss it’s Coming!!! Shortly!!
1 replies
The_Matrix_reloaded_2020 Sep 30, 2:51 PM
$ABCL looking tasty tasty
0 replies
erpy Sep 30, 2:50 PM
$ABCL Are you feeling the bear trap ? Are you feeling the consolidation? Are you ready for the rocket? Jmho
0 replies
Stocktradesmoon Sep 30, 2:30 PM
$ABCL
0 replies
Metacognitive_Drivel Sep 30, 2:21 PM
$ABCL when $20?
0 replies
Stocktradesmoon Sep 30, 2:21 PM
$ABCL We ABOUT to SQUEEZE and GO SUPER GREEN!!!!! Mid-$15’ssss!!! Let’s GO!!!
0 replies
JennyRowes Sep 30, 2:12 PM
$ABCL CEO said they have a long acting next generation hot flashes drug already moving to the clinic. Haven’t seen anything posted on this. did I miss it?
0 replies
Stocktradesmoon Sep 30, 2:06 PM
$ABCL
0 replies